Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors
TAIPEI and SAN DIEGO, July 16, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug Pidnarulex (CX-5461) has been selected by the U.S. National Cancer Institute (NCI) as part of...
Medley Expands Operations in the Philippines to Accelerate Global Growth
MANILA, Philippines, July 16, 2025 /PRNewswire/ -- Medley (TSE: 4480), a leading Japan-based healthcare technology group, has announced the relocation and expansion of its operational functions in the Philippines to help accelerate the company's global business growth. The new office, located at 32nd Street corner 3rd Avenue, Bonifacio Global City (BGC),...
Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
TOKYO, July 16, 2025 /PRNewswire/ -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to develop "aiGait" powered by Uvance, a solution that leverages Fujitsu's advanced skeleton recognition AI technology to detect gait pattern abnormalities, and provide gait quantization to healthcare professionals to support the early diagnosis of...
Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer
HONG KONG, July 16, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration Phase III clinical trial (AK112-312/HARMONi-GI6) of ivonescimab in first-line treatment for advanced metastatic colorectal cancer (mCRC). This randomized, controlled, multi-center Phase III clinical trial for first-line treatment of mCRC is...
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact
- 880 AbbVie employees across 7 markets volunteered over 3,000 hours to support vulnerable groups.- Over 650 individuals benefited from 24 volunteer initiatives, delivered in partnership with 17 community organisations across the region. SINGAPORE, July 16, 2025 /PRNewswire/ -- AbbVie employees in Asia participated in the tenth Week of Possibilities (WOP), the...
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO
SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for Paediatric formulations (GAP-f), the World Health Organization (WHO) host network, ziresovir (10mg) has been included in the PADO-RSV priority list. Ziresovir, developed by Shanghai Ark Biopharmaceutical Co.,...
PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test
FebriDx® is a first-in-class rapid test that differentiates between bacterial and non-bacterial respiratory infections, offering significant potential to address critical unmet needs in patient care by enabling more informed antibiotic use and aiding in the reduction of antimicrobial resistance. Introduction of FebriDx will enhance PHASE Scientific's INDICAID® portfolio and strengthen its...
Avio Health Launches AI Platform to Turn Disconnected Health Data into Preventive Intelligence
How Avio Health Is Rewiring Medicine for the Age of AI PALO ALTO, Calif. , July 15, 2025 /PRNewswire/ -- Today, Avio Health announced the launch of its proprietary clinical AI platform, which is designed to unify health data and support the shift toward preventative, personalized care. By integrating lab results, wearable data, genomics, imaging, and patient histories, the platform...
Introducing the VARON VP-8G: A Smarter, Lighter Portable Oxygen Concentrator Built for Life on the Move
NEW YORK, July 15, 2025 /PRNewswire/ -- For those who need reliable oxygen support without compromising mobility, VARON proudly introduces the VP-8G portable oxygen concentrator — its lightest and most advanced portable oxygen concentrator to date. Engineered for active users, the VP-8G combines powerful performance with effortless portability, offering eight adjustable pulse flow...
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company
BASEL, Switzerland and SEOUL, South Korea, July 15, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families, today announced the appointment of Dr Andreas Niethammer, M.D., Ph.D., as Chief Medical Officer of Vaximm AG, an OSR Company developing a platform of...
